AstraZeneca has reported positive full results from its phase 3 NATRON trial evaluating Fasenra (benralizumab) for the ...

Amgen has reported positive results from its phase 3 VESALIUS-CV trial, which demonstrated that Repatha (evolocumab) ...

Scientists at the University of Edinburgh have identified new drug targets within bacterial cells that could help overcome ...

AstraZeneca has announced positive results from its Bax24 trial of baxdrostat, an investigational treatment for hypertension, ...

Merck (known as MSD outside the US and Canada) has entered into a funding agreement with Blackstone Life Sciences to support ...

Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role ...

Merck (known as MSD outside the United States and Canada) has ended its development partnership with Dr Falk Pharma ...

Support for first and only high-risk smouldering multiple myeloma treatment came from positive phase 3 trial results ...

Lilly will also gain exclusive access to MeiraGTx’s gene therapy platform technologies, including novel intravitreal capsids ...

The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient ...

Cross-functional collaboration is often portrayed as a way to drive innovation. But when done well, another aspect of its ...

Genentech, a member of the Roche Group, has announced positive results from the first of two phase 3 trials investigating ...